Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages 3390-3397

  Nikiforov, Yuri E ^a   Ohori, N Paul ^a   Hodak, Steven P ^a   Carty, Sally E ^a   LeBeau, Shane O ^a   Ferris, Robert L ^a   Yip, Linwah ^a   Seethala, Raja R ^a   Tublin, Mitchell E ^a   Stang, Michael T ^a   Coyne, Christopher ^a   Johnson, Jonas T ^a   Stewart, Andrew F ^a   Nikiforova, Marina N ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BRAF GENE; CANCER RISK; CODON; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASTIC NODULE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PAX8 GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; PPARGAMMA GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTC1 GENE; PTC3 GENE; RET GENE; THYMUS HYPERPLASIA; THYROID ADENOMA; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; BIOPSY, FINE-NEEDLE; DNA MUTATIONAL ANALYSIS; HUMANS; PROSPECTIVE STUDIES; THYROID GLAND; THYROID NODULE;

EID: 80655147350     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1469     Document Type: Article

References (30)

1. Mazzaferri EL 1992 Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 93:359-362
2. Gharib H 2004 Changing trends in thyroid practice: understanding nodular thyroid disease. Endocr Pract 10:31-39
3. Rojeski MT, Gharib H 1985 Nodular thyroid disease. Evaluation and management. N Engl J Med 313:428-436 (Pubitemid 15014039)
4. Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S 1988 Solitary thyroid nodule: diagnosis and management. Med Clin North Am 72:1177-1211
5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
6. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore Jr FD, Larsen PR, Marqusee E, Alexander EK 2006 Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411-3417 (Pubitemid 44402112)
7. Kim DL, Song KH, Kim SK 2008 High prevalence of carcinoma in ultrasonography-guided fine needle aspiration cytology of thyroid nodules. Endocr J 55:135-142 (Pubitemid 351520190)
8. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87: 1941-1946 (Pubitemid 34521470)
9. Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, Groshen S, Singer P, Lopresti J, Martin SE 2000 Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 90:335-341 (Pubitemid 32011844)
10. Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, Lee JE, Evans DB 2003 Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 186:702-709; discussion 709-710
11. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore Jr FD, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK 2007 Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111:508-516 (Pubitemid 350304903)
12. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425-437
13. Ali SZ, Cibas ES 2010 The Bethesda System for Reporting Thyroid Cytopathology. New York: Springer
14. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK 2002 Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 26:41-44
15. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559 (Pubitemid 23053833)
16. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R 2009 BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977-2982
17. Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F 2008 BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 93:3943-3949
18. Yip L, Nikiforova MN, Carty SE, Yim JH, Stang MT, Tublin MJ, Lebeau SO, Hodak SP, Ogilvie JB, Nikiforov YE 2009 Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 146:1215-1223
19. Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH 2010 BRAFV600E mutation analysis in fineneedle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 95:3693-3700
20. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098
21. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95:1365-1369
22. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE 2010 Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance." Cancer Cytopathol 118:17-23
23. Cooper DS, Doherty GM, Haugen BR, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
24. Nikiforov YE 2009 Papillary carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, eds. Diagnostic pathology and molecular genetics of the thyroid. Baltimore: Lippincott, Williams, Wilkins; 160-213
25. Nikiforova MN, Nikiforov YE 2009 Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351-1361
26. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120:71-77 (Pubitemid 37046372)
27. Fagin JA 2002 Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16:903-911
28. Basolo F, Pisaturo F, Pollina LE, Fontanini G, Elisei R, Molinaro E, Iacconi P, Miccoli P, Pacini F 2000 N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 10: 19-23 (Pubitemid 30090361)
29. Garcia-Rostan G, Zhao H, Camp RL, Pollan M, Herrero A, Pardo J, Wu R, Carcangiu ML, Costa J, Tallini G 2003 ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 21:3226-3235 (Pubitemid 46606254)
30. Burns JS, Blaydes JP, Wright PA, Lemoine L, Bond JA, Williams ED, Wynford-Thomas D 1992 Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol Carcinog 6:129-139